BlackRock, Inc. 13D and 13G filings for Relay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Relay Therapeutics, Inc. RLAY | BlackRock Inc. BLK | 14,674,262 8.800% | 5,100,839 (+53.28%) | Filing |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY | BlackRock Inc. BLK | 9,573,423 7.800% | 1,575,438 (+19.70%) | Filing |
| 2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | Relay Therapeutics, Inc. RLAY | BlackRock Inc. BLK | 7,997,985 6.600% | 2,004,372 (+33.44%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Relay Therapeutics, Inc. RLAY | BlackRock Inc. BLK | 5,993,613 5.500% | 5,993,613 (New Position) | Filing |